QR kód

Protein convertase subtilisin/Kexin type 9 inhibits hepatocellular carcinoma growth by interacting with GSTP1 and suppressing the JNK signaling pathway

Objective: Protein convertase subtilisin/Kexin type 9 (PCSK9) has been found to be closely associated with the occurrence and development of numerous tumors. However, the precise role of PCSK9 and its relationship to the development of hepatocellular carcinoma (HCC) remain largely unknown. This stud...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Mingyan He, Jing Hu, Tingting Fang, Wenqing Tang, Bei Lv, Biwei Yang, Jinglin Xia
Médium: Artigo
Jazyk:Inglês
Vydáno: China Anti-Cancer Association 2022-01-01
Edice:Cancer Biology & Medicine
Témata:
On-line přístup:http://www.cancerbiomed.org/index.php/cocr/article/view/1841
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!